Discovery of a Hidden Layer in the Human Genome

A recent study has uncovered a layer of the human genome that was previously overlooked.

Researchers from an international team have identified evidence of more than 1,700 ‘dark’ proteins—essential components of our bodies—stemming from parts of the genome that aren’t typically associated with biological functions.

These small protein-like entities are not standard proteins. Some are so diminutive or unique that researchers have categorized them differently.

“By employing new methods, we’ve named something we observed, recognized its potential for further studies, defined it formally, and made it available for other scientists,” shares pediatric oncologist Sebastiaan van Heesch from the Princess Máxima Center in the Netherlands.

For a long time, it was believed that only a small segment of our DNA contained genes responsible for producing proteins that perform various functions in the body. Much of the genome was dismissed as ‘junk’ DNA, thought to lack any significant purpose.

However, recent advancements in science have significantly reshaped our understanding. This previously ignored DNA landscape has been shown to harbor various switches and regulatory mechanisms influencing normal genes—often referred to as the ‘dark genome’.

“We are entering an incredibly exciting phase in biology,” remarks geneticist Norbert Hübner of the Max Delbrück Center in Germany.

The study suggests that the dark genome might not only modify existing genes but is also responsible for producing a ‘dark proteome’—proteins that deviate from conventional definitions.

“It’s clear that what we currently recognize as proteins doesn’t provide a complete picture,” van Heesch notes.

“This study illustrates that thousands of neglected genetic sequences contribute to the dark proteome, generating a new category of protein-like molecules—microproteins—that we’ve only just discovered.”

The discovery process was quite intensive.

The team began with a list of 7,264 DNA regions identified as non-canonical open reading frames (ncORFs). Although these areas were thought to possibly link to protein formation in a previous study, it remained uncertain how many actually produced detectable molecules.

After analyzing a staggering 3.7 billion data points collected from nearly 96,000 experiments—which took about 20,000 hours of computational time—they identified 1,785 microproteins.

“It was quite a moment when we realized: this is genuinely something novel!” van Heesch recalls.

Most of these dark proteins bear little resemblance to conventional proteins; many are significantly smaller.

The researchers have introduced a new term, ‘peptideins,’ to describe their ambiguous nature (since peptides are essentially short fragments of proteins). While they might function similarly to standard proteins, their precise roles are still largely unknown.

“We’re just starting to explore the potential of this dark proteome,” comments John Prensner, a pediatric neuro-oncologist at the University of Michigan.

“It’s akin to watching a movie trailer—we’re seeing the outline of something transformative in human biology.”

A previous iteration of this research was reported in 2024. Since then, the team has adopted the term peptidein for these microproteins or dark proteins, some of which may evolve into traditional proteins. They have pinpointed one specific peptidein connected to cancer survival. When researchers disabled it in lab studies, cancer cells had difficulty growing.

This not only suggests that peptideins can have functional roles similar to conventional proteins but also hints at their potential in future disease treatments.

“We are genuinely excited about the possibilities that the coming years may bring in addressing and treating human diseases like cancer,” Prensner says.

While there’s still much to learn about these peptideins, the potential seems promising. It sounds like our DNA is far more active and functional than we ever realized.

Hübner adds, “The discovery of hundreds of peptideins highlights a vast, previously overlooked aspect of the genome and significantly broadens the known proteome.”

Comprehending their roles could revolutionize our approach to studying human diseases, including cardiovascular conditions, and may unveil entirely new therapeutic avenues.

This intriguing research has been published in Nature.